BIO-key International
BKYI
13 hedge funds and large institutions have $2.11M invested in BIO-key International in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 6 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
23% more capital invested
Capital invested by funds: $1.71M → $2.11M (+$398K)
0% more ownership
Funds ownership: 0.03% → 0.04% (+0%)
13% less funds holding
Funds holding: 15 → 13 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
55% less call options, than puts
Call options by funds: $653K | Put options by funds: $1.44M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$345K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$102K |
| 3 |
VF
Virtu Financial
New York
|
+$71K |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
+$46K |
| 5 |
Goldman Sachs
New York
|
+$44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$80.9K |
| 2 |
Squarepoint
New York
|
-$77K |
| 3 |
Millennium Management
New York
|
-$74K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$60.5K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$49K |
BKYI Hedge Fund Activity: Q2 2021 in Review
13 of the 5,766 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q2 2021, worth a combined $2.11M — up 23% from $1.71M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of BKYI and 4 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 3 added.
The largest buyer was Vanguard Group, adding an estimated $345K. The largest seller was Citadel Advisors, exiting entirely with an estimated $80.9K sold.
- 13 institutional investors held BIO-key International (BKYI) as of Q2 2021, down from 15 in Q1 2021.
- Funds reported $2.11M of BIO-key International stock for Q2 2021, up 23% quarter-over-quarter.
- 4 funds opened new BIO-key International positions in Q2 2021 and 6 closed out, a net change of -2 holders.
- The largest BIO-key International buyer in Q2 2021 was Vanguard Group, an estimated $345K added.
- The largest BIO-key International seller in Q2 2021 was Citadel Advisors, an estimated $80.9K sold.
Based on aggregated 13F filings for Q2 2021.